COEUS President & CEO, Marc Hixson, named one of the 2022 PM360 Elite 100.
May 17, 2022 – DEVON, PA – COEUS, formerly COEUS Holdings, a leading healthcare communications, technology, talent, and consulting firm delivering a variety of services and platforms to all stakeholders in the healthcare ecosystem, is pleased to announce that its President & CEO, Marc Hixson, has been named a recipient of a 2022 PM360 Elite 100 Award. PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Hixson as one of the 2022 PM360 ELITE 100 in the Transformational Leader category. Now in its eighth year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today.
Since COEUS’ inception in 2009 there has been an emphasis on building service offerings and technologies to help drive the healthcare industry in a more sustainable and financially appropriate direction. Marc’s vision and clear understanding of where the healthcare industry and regulatory bodies are headed has catapulted COEUS and its now five integrated business units into double-digit revenue growth year-over-year for the last decade.
“It’s an honor to be named a Transformational Leader by PM360 for their ELITE 100 Awards,” stated Marc Hixson, President and CEO, COEUS. “Each year PM360 does a stellar job of recognizing industry leaders in a variety of categories so I’m in good company. I’m looking forward to attending the event and meeting the other recipients and the many people who are committed to advancing patient access to innovative, lifesaving therapies.”
The PM360 ELITE Awards were established in 2015 to recognize individuals and teams who have made a significant impact on the life sciences and healthcare industries throughout their careers. More than 500 submissions were received, and nominees were evaluated and selected by the PM360 editorial staff based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts. A total of 100 winners were selected across 20 categories, including Creative Directors, Data Miners, Digital Crusaders, Disrupters, Drug Researchers and Developers, Entrepreneurs, Environmental Champions, Launch Experts, Leaders of the Future, Marketing Teams, Master Educators, Mentors, Patient Advocates, Philanthropic Heroes, PR Gurus, Sales MVPs, Strategists, Talent Acquisition Leaders, Tech-know Geeks, and Transformational Leaders.
“Our industry accomplished great things during the pandemic to ensure people could be protected against COVID, treated for it, and still access all of the other medications they need, but this disruption to our world also revealed ways in which our industry could be even better,” says Anna Stashower, CEO and Publisher of PM360. “Many of this year’s winners sprang into action to improve areas the pandemic exposed as needing changes, including addressing health equity, social determinants of health, clinical research, patient access and affordability, and much more. That’s what makes them the most influential people our industry has to offer—their ability to push the industry forward to make healthcare better for all.”
The winners were profiled in PM360’s May 2022 issue. You can read their profiles online at https://www.pm360online.com/the-2022-pm360-elite-100.
Additionally, the 2022 ELITE 100 will be celebrated at the annual ELITE Awards Event, which will be held at 230 FIFTH in New York City on July 13 th starting at 7 PM EST. A special keynote address from Uber ELITE Winner Mikael Dolsten, MD, PhD, Chief Scientific Officer and President, Worldwide Research, Development, and Medical, Pfizer Inc., will kick off the celebration.
Tickets for the event can be purchased at https://www.pm360online.com/elitetickets.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
Established in 2009, COEUS is a leading healthcare consulting, communications, technology, and talent firm. The company offers clients a variety of services, as well as SaaS technology platforms, for various stakeholders throughout the healthcare ecosystem including all payers and emerging or more established drug manufacturers. Leveraging the deep knowledge and experience of the company’s many subject matter experts, COEUS works on all drug types with a particular focus on cell and gene therapies, rare diseases, and oncology. The company also has unique expertise in the creation and management of value-based agreements by leveraging COEBRA™, the company’s evidence and outcomes adjudication platform. In its 13-year history, the company has supported the launch of more than 120 pharmaceutical brands and has worked with more than 300 pharma clients including many top global pharmaceutical manufacturers. To learn more about COEUS and the company’s offerings, visit 1coeus.com.